成人色图库,粗喘娇吟1V1军婚H,欧美午夜精品久久久,国产欧美日韩A片免费软件,成人欧美一区二区三区黑人免费,欧美日韩一区二区三区在线,国产真人做爰视频免费,久久精品天天爽夜夜爽,国产对白精品刺激一区二区,日本久久久久久级做爰片

發(fā)表期刊：ACS Omega

發(fā)表時(shí)間：2025

Abstract:

Building upon the spectrum-effect relationship theory in traditional Chinese medicine, ultraperformance liquid chromatography (UPLC) was utilized to generate fingerprint profiles for 12 batches of Sanhua Decoction (SHD). These profiles were analyzed in relation to pharmacological efficacy, providing a novel strategy to elucidate the material basis of SHD against cerebral ischemia-reperfusion injury (CIRI) and for efficacy evaluation. The UPLC fingerprints identified 33 common peaks, with 28 chemical constituents characterized. Pharmacodynamic assessment using a rat CIRI model demonstrated that SHD significantly improved neurological deficit scores, reduced cerebral infarct volume, and enhanced brain histopathology, with effects correlated to key indicators such as vascular endothelial growth factor. Gray relational analysis showed that 32 of the 33 peaks had a correlation degree greater than 0.706 with efficacy, confirming the synergistic effect of multiple components in SHD’s anti-CIRI action. Orthogonal partial least-squares discriminant analysis identified 11 potential major active compounds significantly associated with anti-CIRI activity. An “efficacy-integrated fingerprint” was constructed by integrating chemical fingerprinting with pharmacodynamic indices, reflecting the intrinsic quality of SHD. This methodology offers a scientific and efficient approach for chemical constituent investigation and pharmacodynamic material basis elucidation of SHD and other traditional Chinese medicines.

https://doi.org/10.1021/acsomega.5c08547